The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 19, 2019

Filed:

Nov. 06, 2014
Applicant:

Sarepta Therapeutics, Inc., Corvallis, OR (US);

Inventors:

Patrick L. Iversen, Corvallis, OR (US);

David A. Stein, Corvallis, OR (US);

Dwight D. Weller, Corvallis, OR (US);

Assignee:

Sarepta Therapeutics, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C07K 19/00 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); C07K 19/00 (2013.01); C12N 15/111 (2013.01); C12N 2310/11 (2013.01); C12N 2310/314 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/3513 (2013.01); C12N 2310/531 (2013.01); C12N 2320/11 (2013.01); C12N 2770/00011 (2013.01); C12N 2770/10011 (2013.01); C12N 2770/12011 (2013.01); C12N 2770/16011 (2013.01); C12N 2770/20011 (2013.01); C12N 2770/24011 (2013.01); C12N 2770/28011 (2013.01); C12N 2770/32011 (2013.01); C12N 2770/36011 (2013.01);
Abstract

The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Flaviviridae, Picornaviridae, Caliciviridae, Togaviridae, Arteriviridae, Coronaviridae, Astroviridae and Hepeviridae families in the treatment of a viral infection. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with stem-loop secondary structure within the 5'-terminal end 40 bases of the positive-sense RNA strand of the virus.


Find Patent Forward Citations

Loading…